Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.
Mucopolysaccharidosis IVA (MPS IVA; Morquio A syndrome) is a lysosomal storage disorder caused by deficiency of N-acetylgalactosamine-6-sulfatase (GALNS), an enzyme that degrades keratan sulfate (KS). Currently no therapy for MPS IVA is available. We produced recombinant human (rh)GALNS as a potenti...
Main Authors: | Melita Dvorak-Ewell, Dan Wendt, Chuck Hague, Terri Christianson, Vish Koppaka, Danielle Crippen, Emil Kakkis, Michel Vellard |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2922370?pdf=render |
Similar Items
-
Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management
by: Kazuki Sawamoto, et al.
Published: (2020-02-01) -
Role of elosulfase alfa in mucopolysaccharidosis IVA
by: Regier DS, et al.
Published: (2016-06-01) -
Atypical presentation of mucopolysaccharidosis type IVA
by: Eric T. Rush
Published: (2016-09-01) -
Cochlear implantation in a patient with mucopolysaccharidosis IVA
by: Kyoko Nagao, et al.
Published: (2019-08-01) -
Pathophysiology of Hip Disorders in Patients with Mucopolysaccharidosis IVA
by: Zhigang Wang, et al.
Published: (2020-04-01)